Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

819 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transverse colon MALT lymphoma with nodal metastasis.
Yoshimura D, Maruoka A, Maekawa S, Yao T, Harada N, Nawata H. Yoshimura D, et al. Among authors: maekawa s. Gastrointest Endosc. 2002 Feb;55(2):238-9. doi: 10.1067/mge.2002.120101. Gastrointest Endosc. 2002. PMID: 11818929 No abstract available.
Effect of intra-abdominal absorbable sutures on surgical site infection.
Watanabe A, Kohnoe S, Sonoda H, Shirabe K, Fukuzawa K, Maekawa S, Matsuda H, Kitamura M, Matsuura H, Yamanaka T, Kakeji Y, Tsujitani S, Maehara Y. Watanabe A, et al. Among authors: maekawa s. Surg Today. 2012 Jan;42(1):52-9. doi: 10.1007/s00595-011-0024-5. Epub 2011 Nov 10. Surg Today. 2012. PMID: 22068675
Correction to: S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102).
Miyamoto Y, Tsuji A, Tanioka H, Maekawa S, Kawanaka H, Kitazono M, Oki E, Emi Y, Murakami H, Ogata Y, Saeki H, Shimokawa M, Natsugoe S, Akagi Y, Baba H, Maehara Y. Miyamoto Y, et al. Among authors: maekawa s. Int J Clin Oncol. 2018 Apr;23(2):402. doi: 10.1007/s10147-017-1212-0. Int J Clin Oncol. 2018. PMID: 29138948
A prospective study of XELIRI plus bevacizumab as a first-line therapy in Japanese patients with unresectable or recurrent colorectal cancer (KSCC1101).
Ando K, Emi Y, Suenaga T, Hamanoue M, Maekawa S, Sakamoto Y, Kai S, Satake H, Shimose T, Shimokawa M, Saeki H, Oki E, Sakai K, Akagi Y, Baba H, Maehara Y; Kyushu Study Group of Clinical Cancer (KSCC). Ando K, et al. Among authors: maekawa s. Int J Clin Oncol. 2017 Oct;22(5):913-920. doi: 10.1007/s10147-017-1140-z. Epub 2017 May 19. Int J Clin Oncol. 2017. PMID: 28526907 Clinical Trial.
S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102).
Miyamoto Y, Tsuji A, Tanioka H, Maekawa S, Kawanaka H, Kitazono M, Oki E, Emi Y, Murakami H, Ogata Y, Saeki H, Shimokawa M, Natsugoe S, Akagi Y, Baba H, Maehara Y. Miyamoto Y, et al. Among authors: maekawa s. Int J Clin Oncol. 2016 Aug;21(4):705-712. doi: 10.1007/s10147-015-0943-z. Epub 2016 Jan 8. Int J Clin Oncol. 2016. PMID: 26746689 Clinical Trial.
[Departmental review of surgical cases during the past 17 years: Esophageal cancers].
Oga T, Saeki K, Eto A, Hashimoto K, Kimura K, Ito S, Niki M, Nozoe T, Watanabe M, Morita M, Kitamura K, Shiroto Y, Tsutsui S, Nakajima H, Ono M, Fujiya S, Matsuda H, Maekawa S, Kitamura M, Mori M, Matsuura H, Kuwano H, Kai H, Kamio H, Okudaira T. Oga T, et al. Among authors: maekawa s. Fukuoka Igaku Zasshi. 2002 Mar;93(3 Suppl):4-8. Fukuoka Igaku Zasshi. 2002. PMID: 11989241 Review. Japanese. No abstract available.
819 results